Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival Among Children With High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
